Navigation Links
Gerresheimer Finalises Purchase of Spanish Company EDP
Date:1/28/2008

DUSSELDORF, Germany, January 28 /PRNewswire-FirstCall/ -- Gerresheimer AG has quickly completed the takeover of the Spanish PET specialist EDP. The Dusseldorf manufacturer of glass and plastic products for the pharmaceutics and life-science industry announced the purchase, through which it continues its global expansion, on 21 December 2007. EDP with production plants in Spain (Zaragoza and Valencia) and Argentina (Buenos Aires) specialises in pharma containers based on PET, and currently achieves annual sales of around EUR32 million.

Gerresheimer is a pharmaceutical & life science supply and services company with market leading positions of specialty products made of glass and plastic. Gerresheimer owns 38 production sites in Europe, America and Asia and employs approximately 10,000 employees worldwide.

Contact

Burkhard Lingenberg

Director Corporate PR & Marketing

Telephone: +49-211-6181-250

Telefax: +49-211-6181-241

e-mail: b.lingenberg@gerresheimer.com


'/>"/>
SOURCE Gerresheimer AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Gerresheimer Expands its Pharmaceutical Plastic Operations Into Southern Europe and South America
2. Linnartz New Head of Investor Relations of Gerresheimer
3. Growth Trend for Gerresheimer Continues Unabated - Debt Reduction
4. Gerresheimer to be Included in the SDAX Early Decision on Inclusion in the MDAX on September 5, 2007
5. Uninsured Massachusetts Consumer Who Cannot Afford Mandatory Purchase of Health Insurance Flies 3,000 Miles to Speak Out; Is Thrown Out Of Capitol By Speaker Nunez
6. Millennium Enters Into $600,000 Product Development Agreement to Fund Product Development for the $20,000,000 Purchase Agreement with Provider Services, Inc.
7. New Poll: Only 16% of Californians Support Mandatory Purchase of Private Health Insurance; 71% Behind Regulation of Premium Increases
8. AHRQ Releases Consumer Financial Incentives Guide for Employers and Other Health Care Purchasers
9. Stimulating the appetite can lead to unrelated impulse purchases
10. Contact lenses purchased over Internet may place individuals at risk for harmful eyecare practices
11. STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology: